Questionnaires for measuring fatigue and its impact on health perception in inflammatory bowel disease

Revista Espanola de Enfermedades Digestivas

Volumn 105, Issue 3, 2013, Pages 144-153

  Castillo Cejas, María Dolores ^a   Robles, Virginia ^a   Borruel, Natalia ^a   Torrejón, Antonio ^a   Navarro, Ester ^a   Peláez, Andrés ^a   Casellas, Francesc ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Fatigue; Inflammatory bowel disease; Quality of life; Questionnaire; Validation

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CROSS-SECTIONAL STUDY; DAILY FATIGUE IMPACT SCALE; DISEASE ACTIVITY; DISEASE SEVERITY; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED FATIGUE IMPACT SCALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; PSYCHOMETRY; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REMISSION; ULCERATIVE COLITIS; VALIDATION PROCESS; COMPLICATION; EVALUATION STUDY; HEALTH IMPACT ASSESSMENT; MIDDLE AGED; PROCEDURES; SELF EVALUATION;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DIAGNOSTIC SELF EVALUATION; FATIGUE; FEMALE; HEALTH IMPACT ASSESSMENT; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84879648255     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082013000300005     Document Type: Article

References (43)

1. Nugent FW, Haggitt RC, Gilpin P. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-1248.
2. Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, et al. Infliximab maintenance therapy is associated with decrease in direct resource use in patients with luminal or fistulizing Crohn's disease. J Clin Gastroenterol 2009;43:950-956.
3. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607.
4. Casellas F, López Vivancos J, Sampedro M, Malagelada JR. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 2005;100:2737-2742.
5. Casellas F, Arenas JI, Baudet JS, Fabregas S, Garcia N, Gelabert J, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: A Spanish multicenter study. Inflamm Bowel Dis 2005;11:488-496.
6. Casellas F, López-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res 2002;11:775-781.
7. Vergara M, Montserrat A, Casellas F, Gallardo O, Suarez D, Motos J, et al. Development and validation of the Crohn's disease perceived work disability questionnaire. Inflamm Bowel Dis 2011;17:2350-2357.
8. Casellas F, López-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol 2001;13:567-572.
9. Velarde-Jurado E, Ávila-Figueroa C. Evaluación de la calidad de vida. Salud Pública Mex 2002;44:349-361.
10. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-629.
11. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996;334:835-840.
12. Lock K. Health impact assessment. BMJ 2000;320:1395-1398.
13. Casellas F, Rodrigo L, López Vivancos J, Riestra S, Pantiga C, Baudet JS, et al. Factors that impact health-related quality of life in adults with celiac disease: A multicenter study. World J Gastroenterol 2008;14:46-52.
14. Jelsness-Jørgensen LP, Bernklev T, Henriksen M Torp R, Moum BA. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bow Dis 2011;17:1564-1572.
15. Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bow Dis 2011;17:1882-1889.
16. Jelsness-Jørgensen LP, Bernklev T, Henriksen M Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther 2011; 33:106-114.
17. Langenberg DR, Gibson PR. Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 2010;32:131-143.
18. Swain MG. Fatigue in chronic disease. Clin Sci 2000;99:1-8.
19. Lee KA, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res 1991;36:291-8.
20. Stange EF, Travis SPL, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based consensus on the management of ulcer-ative colitis: definitions and diagnosis. J Crohns Colitis 2008;2:1-23.
21. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004; 126:1518-1532.
22. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus and implications. Gut 2006;55:749-753.
23. Kos D, Kerckhofs E, Carrea I, Verza R, Ramos M, Jansa J. Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler 2005;11:76-80.
24. Jones DE, Gray JC, Newton J. Perceived fatigue is comparable between different disease groups. QJM 2009;102:617-624.
25. Valko PO, Bassetti CL, Bloch KE. Validation of the Fatigue Severity Scale in a Swiss cohort. Sleep 2008;31:1601-1607.
26. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-1123.
27. Kos D, Kerckohfs E, Carrea I, Verza R, Ramos M, Jansa J. Evaluation of the Modified Fatigue Impact Scale in four different European countries. Mult Scler 2005;11:76-80.
28. Badia X, Roset M, Herdman, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 2001;21:7-16.
29. Badia X, Schiaffino A, Alonso J, Herdman M. Using the EuroQol 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res 1998;7:311-322.
30. Höfer S, Kullich W, Graninger U, Wonisch M, Gassner A, Klicpera M, et al. Cardiac rehabilitation in Austria: long term health-related quality of life outcomes. Health Qual Life Outcomes 2009;7:99.
31. Harrison MJ, Lunt M, Verstappen SM, Watson KD, Bansback NJ, Symmons DP. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis. Health Qual Life Outcomes 2010;8:21.
32. Pérez-San Gregorio MA, Martín-Rodríguez A, Pérez-Bernal J, Mal-donado MD. Quality of Life in Spanish patients with liver transplant. Clin Pract Epidemiol Ment Health 2010;6:79-85.
33. Huamán JW, Casellas F, Borruel N, Peláez A, Torrejón A, Castells I, et al. Cutoff values of the inflammatory bowel disease questionnaire to predict a normal health related quality of life. J Crohns Colitis 2010;4:637-641.
34. Janssen MF, Birnie E, Bonsel GJ. Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods. Qual Life Res 2008;17:463-473.
35. Craig BM, Busschbach JJV, Salomon JA. Modeling ranking, time tradeoff and visual analogue scale values for EQ-5D health states: A review and comparison of methods. Med Care 2009;47:634-641.
36. Masachs M, Casellas F, Borruel N, Torrejón A, Castells I, Malagelada JR. Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD). Inflamm Bowel Dis 2010;16:982-992.
37. Montejo AL, Correas-Lauffer J, Mauriño J, Villa G, Rebollo P, Díez T, et al. Estimation of a multiattribute utility function for the Spanish Version of the TooL Questionnaire. Value Health 2011;14:564-570.
38. Masachs M, Casellas F, Malagelada JR. Spanish translation, adaptation and validation of the 32-item quality of life questionnaire (IBDQ-32) for inflammatory bowel disease. Rev Esp Enferm Dig 2007; 99:511-519.
39. Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005;11:909-918.
40. López-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada JR. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease. Digestion 1999;60:274-280.
41. Alcalá MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis 2004;10:383-91.
42. Jelsness-JØrgensen LP, Bernklev T, Henriksen M, Torp R, Moum B. Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease. World J Gastroenterol 2012;18:445-452.
43. Römkens TE, van Vugt-van Pinxteren MW, Nagengast FM, van Oijen MG, de Jong DJ. High prevalence of fatigue in inflammatory bowel disease: A case control study. J Crohns Colitis 2011;5:332-337.